The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Marken James G. since 2014.
This trader's CIK number is 1579587.
At the time of last reporting, Marken James G. was the SVP OPS & PROD DEV of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP).
Also see all insider trading activities at Ani Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ANIP | 0 | $0 | 24,338 | $1,615,313 | 12,550 | $668,726 |
| 2023 | ANIP | 0 | $0 | 3,932 | $247,716 | 5,417 | $199,318 |
| 2022 | ANIP | 0 | $0 | 18,066 | $673,071 | 0 | $0 |
| 2019 | ANIP | 0 | $0 | 13,824 | $975,171 | 0 | $0 |
| 2018 | ANIP | 0 | $0 | 4,177 | $258,639 | 18,001 | $354,259 |
| 2015 | ANIP | 0 | $0 | 18,500 | $1,148,910 | 16,415 | $224,545 |
| 2014 | ANIP | 0 | $0 | 5,000 | $171,400 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-07 | ANIP | Option Ex | 12,550 | 53.28 | 668,726 |
| 2024-03-07 | ANIP | Sale | 24,338 | 66.37 | 1,615,313 |
| 2023-08-23 | ANIP | Option Ex | 5,417 | 36.80 | 199,318 |
| 2023-08-23 | ANIP | Sale | 3,932 | 63.00 | 247,716 |
| 2022-08-12 | ANIP | Sale | 12,894 | 37.04 | 477,606 |
| 2022-08-15 | ANIP | Sale | 5,172 | 37.79 | 195,465 |
| 2019-05-17 | ANIP | Sale | 8,907 | 70.67 | 629,457 |
| 2019-05-14 | ANIP | Sale | 4,917 | 70.31 | 345,714 |
| 2018-03-05 | ANIP | Option Ex | 18,001 | 19.68 | 354,259 |
| 2018-03-05 | ANIP | Sale | 4,177 | 61.92 | 258,639 |
| 2015-12-18 | ANIP | Sale | 3,500 | 43.26 | 151,410 |
| 2015-07-17 | ANIP | Option Ex | 7,395 | 6.36 | 47,032 |
| 2015-05-13 | ANIP | Option Ex | 9,020 | 19.68 | 177,513 |
| 2015-03-19 | ANIP | Sale | 15,000 | 66.50 | 997,500 |
| 2014-06-18 | ANIP | Sale | 5,000 | 34.28 | 171,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Marken James G. (SVP OPS & PROD DEV of Ani Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.